Exam (elaborations)
ASCP SCYM study Questions and Answers 100% Solved 2024/2025
- Course
- Institution
ASCP SCYM study Questions and Answers 100% Solved 2024/2025
[Show more]
Seller
Follow
Legitexams
Reviews received
Content preview
ASCP SCYM studySample Processing - ANSOptimized antibody concentration
Defined range of cell #
Define sample handling, time and temperature
Define acceptable time of delay for acquisition
CD2 - ANST cells: NK cells
CD3 - ANST cells
CD4 - ANST helper cells, monocytes (dimly expressed)
CD5 - ANST cells; Some B Cells
CD8 - ANST cytotoxic cells, macrophages
CD10 - ANSImmature T, B Cells, PMN's
CD13 - ANSMonocytes, PMN's
CD14 - ANSMonocytes, PMN's (dimly expressed)
CD16 - ANSNK cells, PMN's, monocytes
CD19 - ANSB Cells
CD20 - ANSB Cells
CD25 - ANSActivated T Cells
CD33 - ANSMonocytes
CD34 - ANSStem/Progenitor Cells
CD45 - ANSLeukocytes
CD56 - ANSNK cells, monocytes (dimly expressed)
Anti-Kappa - ANSB Cells
Anti-Lambda - ANSB Cells
,Tdt - ANSImmature Lymphocytes
Monoclonal Antibody Staining Direct Staining - ANSRapid single step staining
Can use multiple antibodies from the same host
Monoclonal Antibody Staining Indirect Staining - ANSSecondary amplifies single
A few labeled secondaries can detect many primaries
Clinical Applications of Flow - ANS-Instrument Performance
-Integrity of the Specimen
-Quality in Processing of Specimens
-Appropriate Reagents and Controls
-Qualified Technical Staff
-Regulatory requirements from CAP, TJC, CLIA, and the FDA exist to ensure the accurate
reporting of flow cytometric results.
Lymphocytes Subset Enumeration (Immunophenotyping) - ANS2 Tubes: 1-
CD3/CD4/CD8/CD45
2- CD3/CD19/CD16&CD56/CD45
-May include analysis of CD4 and CD8 T Cells, B Cells and NK Cells.
-Results reported as proportion (%) of total lymphocyte population.
CD4 Counts in HIV Infection - ANS-Asses degree of immunodeficiency
-Diagnose of AIDS
-Institution of Anti-Retroviral (ARV) therapy and opportunistic infection (OI) prophylaxis
-Monitoring immune reconstitution
CD4 Immunophenotyping Panels - ANS
2 color - ANSIsotype Ctrl
CD45/CD14
CD3/CD4
CD3/CD8
CD3/CD19
CD3/CD16 + 56
3 Color - ANSCD3/CD4/CD45
CD3/CD8/CD45
CD3/CD19/CD16 + 56
4 Color - ANSCD3/CD4/CD8/CD45
CD3/CD16/CD16 + 56/CD45
, Determination of Absolute Counts - ANS-Subset % X Absolute Lymphocyte Count
-Counting Beads- known concentration present in staining tube or added to tube
-Volumetric Cytometers
Leukemia/Lymphoma Phenotyping - ANS-Important in Diagnosis, Classification and Monitoring
of patients with hematologic malignancies.
-Utility based on the fact that hematopoiesis is characterized by the gain and loss of cell surface
and intracellular antigen during the process of maturation.
-Malignant cells may have a block at an immature stage resulting in abnormal numbers of
immune cells. With a mature phenotype may be present in abnormally high numbers. May have
an aberrant phenotype.
Leukemia/Lymphoma Phenotyping FC - ANS-Analysis with panels of monoclonal antibodies
allows for lineage assignment and sub classification that may have further prognostic
significance.
-The identification of a unique phenotype can also facilitate post-therapy monitoring to assess
residual disease.
Relevance for the Diagnosis and Classification of Hematologic Malignancies - ANS-Expression
of aberrant lineage associated antigen
-Absence of lineage associated antigen
-Asynchronous expression of antigens
-Abnormal level of expression of antigen
Detection of Fetal Hemoglobin - ANS-Detection of fetal hemoglobin containing cells in useful for
the diagnosis and management of feto-maternal hemorrhage
-Traditionally assayed with the Kleihauer-Betke method
-FC offers improved sensitivity (<0.02% fetal RBCs) and reproducibility (CV <15%
-Method: Intracellular staining with a fetal hemoglobin specific monoclonal antibody
CD34 Stem Cell Enumeration - ANS-Present on immature hematopoietic cells
-Expression is lost as cells mature
-Used as a marker to identify and enumerate stem cells in bone marrow and peripheral blood
products for transplantation
-Currently the Gold Standard for assessment of HSC products for transplant
CD3 Transplant Monitoring - ANS-Acute graft rejection is an important complication after solid
organ transplantation that may lead to graft loss
-Severe cases of rejection may be treated with antibodies that deplete T cells from the patient
(OKT3, ATG)
-FC is used to assess the effectiveness of T cell depletion after antibody based anti-rejection
therapy
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Legitexams. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for R205,29. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
73918 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy summaries for 14 years now